Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016, Article ID 8580750, 7 pages
Research Article

Long-Term Clinical Outcomes of Invasive Giant Prolactinomas after a Mean Ten-Year Followup

1Department of Neurosurgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
2Department of Neurosurgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Received 10 July 2016; Accepted 24 October 2016

Academic Editor: Aldo E. Calogero

Copyright © 2016 Ze Rui Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [5 citations]

The following is the list of published articles that have cited the current article.

  • Bruce E. Pollock, Fredric B. Meyer, Christopher Salvatore Graffeo, Nicholas M. Wetjen, Avital Perry, and Christopher Marcellino, “Pediatric Pituitary Adenoma: Case Series, Review of the Literature, and a Skull Base Treatment Paradigm,” Journal of Neurological Surgery, Part B: Skull Base, vol. 79, no. 1, pp. 91–114, 2018. View at Publisher · View at Google Scholar
  • Souha S Elabd, Maswood M Ahmad, Sameer Q Qetab, and Mussa Hussain Almalki, “Cabergoline-Induced Pneumocephalus Following Treatment for Giant Invasive Macroprolactinoma Presenting With Spontaneous Cerebrospinal Fluid Rhinorrhea,” Clinical Medicine Insights: Endocrinology and Diabetes, vol. 11, 2018. View at Publisher · View at Google Scholar
  • Qun Li, Zhipeng Su, Jianglong Lu, Chengde Wang, Jiaqing Guan, Xianbin Chen, Jinsen Wu, Weiming Zheng, Zhebao Wu, Zerui Wu, and Lin Cai, “MicroRNA-93 mediates cabergoline resistance by targeting ATG7 in prolactinoma,” Journal of Endocrinology, vol. 240, no. 1, pp. 1–13, 2018. View at Publisher · View at Google Scholar
  • P. Souteiro, and N. Karavitaki, “Dopamine agonist resistant prolactinomas: any alternative medical treatment?,” Pituitary, 2019. View at Publisher · View at Google Scholar
  • Nicolas Sahakian, Frederic Castinetti, Henry Dufour, Thomas Graillon, Pauline Romanet, Anne Barlier, Thierry Brue, and Thomas Cuny, “Clinical management of difficult-to-treat macroprolactinomas,” Expert Review of Endocrinology & Metabolism, 2019. View at Publisher · View at Google Scholar